Scott Gottlieb, who won praise for trying to do his regulatory job, is quitting the FDA

Indonesia Berita Berita

Scott Gottlieb, who won praise for trying to do his regulatory job, is quitting the FDA
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 latimes
  • ⏱ Reading Time:
  • 41 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 82%

Scott Gottlieb, possibly Trump's only effective regulator, announces his departure from the FDA — but what will come of his initiatives? hiltzikm weighs in:

As recently as Tuesday morning, Gottlieb appeared on CNBC to announce a crackdown on 15 national retailers for selling tobacco and e-cigarettes to minors, giving no clue about the announcement he was to make a few hours later. There were no indications that he was pressured to resign; in fact, his image as an effective regulator was one of the few examples of functioning government that Trump could point to.

“He was entangled in an unprecedented web of ties to Big Pharma,” says Michael Carome, director of the Health Research Group at Public Citizen, which opposed his confirmation. He was labeledwhose appointment was greeted with unalloyed joy by the drug industry. But even some healthcare advocates were relieved that Gottlieb got the job over such candidates as Peter Thiel, a Silicon Valley billionaire with an extreme anti-regulatory bent.

In office, Gottlieb won positive reviews for some of his regulatory initiatives on public health issues such as opioid abuse, the rise of vaping among underage users, and clinics hawking bogus stem cell “cures” for incurable diseases. He had pledged to streamline the FDA process for approving drugs, which brought him praise from some patient advocates.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

latimes /  🏆 11. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

FDA Commissioner Scott Gottlieb is resigningFDA Commissioner Scott Gottlieb is resigning
Baca lebih lajut »

FDA Commissioner Scott Gottlieb resignsFDA Commissioner Scott Gottlieb resignsFood and Drug Administration Commissioner Scott Gottlieb has resigned and plans to leave the agency in a month.
Baca lebih lajut »

FDA Commissioner Scott Gottlieb to step downFDA Commissioner Scott Gottlieb to step downGottlieb noted his work to reduce tobacco use, discourage teen use of e-cigarettes, address the opioid epidemic and improve access to generic drugs.
Baca lebih lajut »

FDA Chief Scott Gottlieb to Leave AgencyFDA Chief Scott Gottlieb to Leave AgencyScott Gottlieb, the Food and Drug Administration commissioner who has presided over initiatives to limit the sale of e-cigarettes to children, is resigning.
Baca lebih lajut »

FDA Commissioner Scott Gottlieb just resigned as head of the US's top food and drug regulatorFDA Commissioner Scott Gottlieb just resigned as head of the US's top food and drug regulatorGottlieb worked in the healthcare industry before joining the Food and Drug Administration as its top official during the Trump administration.
Baca lebih lajut »

Trump FDA chief and vaping foe Scott Gottlieb resignsTrump FDA chief and vaping foe Scott Gottlieb resignsGottlieb, who'd fought against electronic cigarettes and opioid addiction, is reportedly leaving to spend more time with his family.
Baca lebih lajut »

FDA Chief Scott Gottlieb Has ResignedFDA Chief Scott Gottlieb Has ResignedThe FDA commissioner took stands against teen vaping and online opioid sales. His resignation letter did not explain why he was stepping down now.
Baca lebih lajut »

FDA chief Scott Gottlieb resigning, reports sayFDA chief Scott Gottlieb resigning, reports say
Baca lebih lajut »

FDA Commissioner Scott Gottlieb resignsFDA Commissioner Scott Gottlieb resignsFood and Drug Administration Commissioner Scott Gottlieb is stepping down after nearly two years leading the agency’s response to a host of public health challenges, including the opioid epidemic, rising drug prices and underage vaping.
Baca lebih lajut »



Render Time: 2025-04-09 12:48:43